During the past decade, Northwestern Univ / Infect Dis Div / Pasavant Pav 828 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Northwestern Univ / Infect Dis Div / Pasavant Pav 828" are "HIV Infections" (2 trials). Many other conditions were trialed in "Northwestern Univ / Infect Dis Div / Pasavant Pav 828" in a lesser frequency.

Most popular intervention types in "Northwestern Univ / Infect Dis Div / Pasavant Pav 828" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enfuvirtide" (1 trials), "Indinavir sulfate" (1 trials) and "Ritonavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Univ / Infect Dis Div / Pasavant Pav 828" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Northwestern Univ / Infect Dis Div / Pasavant Pav 828". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Northwestern Univ / Infect Dis Div / Pasavant Pav 828, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Univ / Infect Dis Div / Pasavant Pav 828, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".